Tag Archives: masitinib

Differential Properties of Existing Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

Demetri, GD “SEMINARS IN ONCOLOGY APR 2011″ During the previous ten years, tyrosine kinase inhibitors (TKIs) have revolutionized the remedy of gastrointestinal stromal tumors (GIST), supplying new treatment choices with unprecedented medical benefit. Recognition with the key function played by … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Directed Therapy of Subtypes of Triple-Negative Breast Cancer

Carey, LA “ONCOLOGIST 2011″ Masitinib can boost the antiproliferative results of gemcitabine (GEM) in human pancreatic cancer cells. It potently inhibited human and murine Package with activating mutations within the juxtamembrane domain. In vivo, masitinib blocked tumour growth in mice … Continue reading

Posted in Uncategorized | Tagged | Leave a comment